The Cigna Group (CI) Quarterly Income Statement

Quarterly · GAAP · USD millions
Access CI Annual Income Statement →
Income statement data covering The Cigna Group–Mar 31 2025 offers a view into how Mar 31 2026's operating results have moved alongside business activity.
Quarterly Report, GAAP in USD millions
ITEM
(Mar 31 2026)
Q1 2026
(Dec 31 2025) (Sep 30 2025) (Jun 30 2025) (Mar 31 2025)
Revenues
Premiums Earned, Net9,812.00
Revenue From Contract With Customer Excluding Assessed Tax54,037.00
Other Revenue4,443.00
Total Revenue68,494.00
Costs & Expenses
Cost of Goods and Services Sold54,100.00
Policyholder Benefits and Claims Incurred, Net7,924.00
Gross Profit6,470.00
Selling, Administration, Marketing3,722.00
Gain (Loss) on Disposition of Assets and Investments11.00
Depreciation & Amortization390.00
Restructuring0.00
Other operatinig exp. /-income-11.00
Operating Costs66,136.00
Interest Expense, Borrowing357.00
Net Interest Expense / Income0.00
Other loss/ -income346.00
Total Costs & Expenses66,224.00
Income & Taxes
Income / Loss Before Income Taxes2,270.00
Income Taxes Expense / Benefit409.00
Income After Income Taxes1,861.00
Income / Loss from Continuing Operations1,861.00
Net Income / Loss1,861.00
Non-controlling Interests207.00
Income / Loss Attributable to Shareholders1,654.00
EBIT2,270.00
EBITD2,920.00
EBITDA2,920.00
Earnings Per Share
Basic EPS (excl. extra items)6.30
Basic Net EPS6.30
Basic shares outstanding (Mill. of Units)262.75
Diluted Net EPS6.26
Diluted average shares (Mill. of Units)264.02
Dividend per share1.56
4 historic quarters locked

Sign in to unlock the full The Cigna Group income statement history.

About Cigna Group Quarterly Income Statement

What this statement shows

This page presents issuer-reported income statement data, detailing revenue, operating costs, expenses, and earnings as disclosed in SEC 10-Q filings and standardized by CSIMarket. The income statement reflects operating performance over a reporting period rather than financial position at a single date.

Revenue and expense treatment

Revenue and expense items are aligned to support period-to-period comparability. Operating and non-operating items, interest, and income taxes are classified based on issuer disclosures and XBRL tagging.

Source & verification

  • Source: SEC 10-Q filings
  • Filed with the SEC: July 30, 2026
  • Original filing: ci-20260630.htm

Income statement figures represent operating results for each reporting period and may be revised in subsequent filings.